Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin - PubMed

Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin

D Pende et al. Eur J Immunol. 2001 Apr.

Free article

Abstract

NKG2D is a recently described activating receptor expressed by both NK cells and CTL. In this study we investigated the role of NKG2D in the natural cytolysis mediated by NK cell clones. The role of NKG2D varied depending on the type of target cells analyzed. Lysis of various tumors appeared to be exclusively natural cytotoxicity receptors (NCR) dependent. In contrast, killing of another group of target cells, including not only the epithelial cell lines HELA and IGROV-1, but also the FO-1 melanoma, the JA3 leukemia, the Daudi Burkitt lymphoma and even normal PHA-induced lymphoblasts, involved both NCR and NKG2D. Notably, NK cell clones expressing low surface densities of NCR (NCR(dull)) could lyse these tumors in an exclusively NKG2D-dependent fashion. Remarkably, not all of these targets expressed MICA/B, thus implying the existence of additional ligands recognized by NKG2D, possibly represented by GPI-linked molecules. Finally, we show that the engagement of different HLA class I-specific inhibitory receptors by either specific antibodies or the appropriate HLA class I ligand led to inhibition of NKG2D-mediated NK cell triggering.

Similar articles

• Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

  Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L. Moretta A, et al. Annu Rev Immunol. 2001;19:197-223. doi: 10.1146/annurev.immunol.19.1.197. Annu Rev Immunol. 2001. PMID: 11244035 Review.

• Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.

  Pende D, Rivera P, Marcenaro S, Chang CC, Biassoni R, Conte R, Kubin M, Cosman D, Ferrone S, Moretta L, Moretta A. Pende D, et al. Cancer Res. 2002 Nov 1;62(21):6178-86. Cancer Res. 2002. PMID: 12414645

• Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.

  Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina TL, Campbell KS, Santoli D. Brando C, et al. J Leukoc Biol. 2005 Aug;78(2):359-71. doi: 10.1189/jlb.0604360. Epub 2005 Jun 3. J Leukoc Biol. 2005. PMID: 15937142

• HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.

  Carbone E, Neri P, Mesuraca M, Fulciniti MT, Otsuki T, Pende D, Groh V, Spies T, Pollio G, Cosman D, Catalano L, Tassone P, Rotoli B, Venuta S. Carbone E, et al. Blood. 2005 Jan 1;105(1):251-8. doi: 10.1182/blood-2004-04-1422. Epub 2004 Aug 24. Blood. 2005. PMID: 15328155

• Human natural killer cell receptors and co-receptors.

  Biassoni R, Cantoni C, Pende D, Sivori S, Parolini S, Vitale M, Bottino C, Moretta A. Biassoni R, et al. Immunol Rev. 2001 Jun;181:203-14. doi: 10.1034/j.1600-065x.2001.1810117.x. Immunol Rev. 2001. PMID: 11513142 Review.

Cited by

• The Roles of Alternative Splicing in Tumor-immune Cell Interactions.

  Wang Y, Zhang H, Jiao B, Nie J, Li X, Wang W, Wang H. Wang Y, et al. Curr Cancer Drug Targets. 2020;20(10):729-740. doi: 10.2174/1568009620666200619123725. Curr Cancer Drug Targets. 2020. PMID: 32560607 Free PMC article. Review.

• Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells.

  Kato N, Tanaka J, Sugita J, Toubai T, Miura Y, Ibata M, Syono Y, Ota S, Kondo T, Asaka M, Imamura M. Kato N, et al. Leukemia. 2007 Oct;21(10):2103-8. doi: 10.1038/sj.leu.2404862. Epub 2007 Jul 12. Leukemia. 2007. PMID: 17625602

• HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts.

  Ward J, Bonaparte M, Sacks J, Guterman J, Fogli M, Mavilio D, Barker E. Ward J, et al. Blood. 2007 Aug 15;110(4):1207-14. doi: 10.1182/blood-2006-06-028175. Epub 2007 May 18. Blood. 2007. PMID: 17513617 Free PMC article.

• Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function.

  Carreira-Santos S, López-Sejas N, González-Sánchez M, Sánchez-Hernández E, Pera A, Hassouneh F, Durán E, Solana R, Casado JG, Tarazona R. Carreira-Santos S, et al. Front Immunol. 2023 Oct 16;14:1256404. doi: 10.3389/fimmu.2023.1256404. eCollection 2023. Front Immunol. 2023. PMID: 37908353 Free PMC article.

• Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.

  Carreno BM, Garbow JR, Kolar GR, Jackson EN, Engelbach JA, Becker-Hapak M, Carayannopoulos LN, Piwnica-Worms D, Linette GP. Carreno BM, et al. Clin Cancer Res. 2009 May 15;15(10):3277-86. doi: 10.1158/1078-0432.CCR-08-2502. Epub 2009 May 15. Clin Cancer Res. 2009. PMID: 19447870 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program